Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
We suggest to investigate serotonin uptake in schizophrenia patients receiving ECT
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Inclusion Criteria:
Participants must meet DSM-IV criteria for schizophrenia, as assessed by the Structured Clinical Interview - Patient Version (SCID) (First et al., 1995).
Ages 18 -55 Men and/or women -
Exclusion Criteria:
History of neurological disorders, active substance abuse in the previous 3 months.
Estimated IQ less then 70.
SSRIs treatment 4 weeks prior to the study.
Any subject suffering from inflammatory fever disease will be excluded from the study.
-
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Avi Peled, MD | Contact | 972522844050 | av_peled@netvision.net.il |
| Name | Affiliation | Role |
|---|---|---|
| Avi Peled, MD | Shaar Menashe MHC | Principal Investigator |
| Ilan Modai, M.D. MHA | Shaar Menashe | Principal Investigator |
| Moshe Rehavi, Ph.D. |
Not provided
Not provided
| ID | Term |
|---|---|
| D012559 | Schizophrenia |
| ID | Term |
|---|---|
| D019967 | Schizophrenia Spectrum and Other Psychotic Disorders |
| D001523 | Mental Disorders |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| TAU |
| Principal Investigator |